Scalable MSC Manufacturing Matters in a Rapid Response to COVID-19 March 13, 2020 Biomanufacturing, Cell Therapy, Corporate, COVID-19
WHITE PAPER: The Stabilization of hMSCs as a Technology March 05, 2020 BioEconomy, Biomanufacturing, Cell Therapy, Corporate
Best Practices in MSC Culture: Tracking & Reporting Cellular Age Using Population Doubling Level… October 07, 2019 Biomanufacturing, MSCs & Characterization
Meeting the Growing Needs of the Perinatal RegenMed Industry: the Only Umbilical Cord hMSC System… September 18, 2019 MSCs & Characterization
RoosterBio Products Continue to Expand Presence in Major Mesenchymal Stem/Stromal Cell (MSC)-related… November 17, 2018 Corporate
Comparability of hMSC Economic & Quality Attributes after Expansion in Bovine Serum-Containing vs… May 10, 2016 MSCs & Characterization
